NCT06576674

Brief Summary

The goal of this pilot study is to identify the role of satiety on responses to alcohol drinking using human subject laboratory methods. Satiety will be manipulated over two sessions using a dietary supplement (fiber+green tea) or a calorically matched placebo. Responses to an acute alcohol challenge are measured.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 29, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

September 3, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2025

Completed
8 months until next milestone

Results Posted

Study results publicly available

December 5, 2025

Completed
Last Updated

December 5, 2025

Status Verified

August 1, 2025

Enrollment Period

7 months

First QC Date

August 26, 2024

Results QC Date

November 20, 2025

Last Update Submit

November 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Alcohol Specific Satiety Score

    The Alcohol-specific Satiety Questionnaire is a 16-item instrument designed to measure satiety to alcohol's effects. Ratings are made from Not at all; 0 to Extremely; 10, yielding total scores from 0 to 160 with higher values representing greater alcohol-specific satiety.

    baseline to 60 minutes

Secondary Outcomes (5)

  • Change in Positive Affect Based on Subjective Effects of Alcohol Scale Score

    baseline to 60 minutes

  • Change in Subjective Stimulation (Biphasic Alcohol Effects Scale)

    baseline to 60 minutes

  • Change in Attention Bias to Alcohol Score

    30 minutes after alcohol administration

  • Change in Alcohol Demand Score

    baseline to 60 minutes

  • Change in Alcohol Urge Questionnaire Score

    baseline to 60 minutes

Study Arms (2)

dietary supplement, then placebo

EXPERIMENTAL

Participants receive a dietary supplement at the first study session (10g Fibersol®-2 mixed with water and aspartame sweetener + 725mg decaffeinated green tea extract capsule), and then the next study session they receive the placebo supplement (Aspartame sweetener mixed with water + aspartame capsule). Participants will also receive a drink containing alcohol (vodka + cranberry mixer) on both sessions.

Dietary Supplement: Dietary Fiber + Green Tea ExtractOther: AlcoholOther: Aspartame Placebo Supplement

placebo, then dietary supplement

EXPERIMENTAL

Participants receive a placebo supplement at the first study session (Aspartame sweetener mixed with water + aspartame capsule), then the next session they receive the dietary supplement (10g Fibersol®-2 mixed with water and aspartame sweetener + 725mg decaffeinated green tea extract capsule). Participants will also receive a drink containing alcohol (vodka + cranberry mixer) on both sessions.

Dietary Supplement: Dietary Fiber + Green Tea ExtractOther: AlcoholOther: Aspartame Placebo Supplement

Interventions

Aspartame sweetener mixed with water + aspartame capsule

Also known as: Equal
dietary supplement, then placeboplacebo, then dietary supplement

10g fiber + 750mg green tea supplement will be administered at experimental arm

Also known as: Fibersol®-2, decaffeinated green tea extract
dietary supplement, then placeboplacebo, then dietary supplement
AlcoholOTHER

alcohol administered up to a target BAC 0.06g/dL during lab sessions

Also known as: ethanol (ETOH)
dietary supplement, then placeboplacebo, then dietary supplement

Eligibility Criteria

Age21 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 21-45
  • Meeting NIAAA criteria for current at-risk drinking (i.e., \>7/14 drinks in one week for women/men, with at least one episodes of 4+/5+ drinks in the past 30 days)
  • Willingness to complete laboratory sessions involving blood draws and alcohol administration
  • Ability to communicate and read in English
  • Body mass index (BMI) of 21 - 30 kg/m\^2

You may not qualify if:

  • Meets past-year criteria for severe Alcohol Use Disorder (\>7 of 11 symptoms endorsed) or AUDIT score of 20+
  • Meeting past-year criteria for a substance use disorder (with the exception of alcohol, tobacco or mild cannabis use disorder)
  • Current engagement in alcohol treatments, or currently engaged in intentional efforts to quit alcohol use
  • Current use of weight control medications
  • Lifetime diagnosis of severe mental illness (including schizophrenia and bipolar disorder)
  • History of suicide attempt, or psychiatric hospitalization in the last 6 months
  • History of diabetes
  • Medical conditions or medications for which alcohol is contraindicated
  • Pregnant, nursing, or trying to become pregnant
  • Plans to travel during the duration of study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina

Chapel Hill, North Carolina, 27599, United States

Location

MeSH Terms

Conditions

Alcohol Drinking

Interventions

Dietary FiberTeaEthanol

Condition Hierarchy (Ancestors)

Drinking BehaviorBehavior

Intervention Hierarchy (Ancestors)

Dietary CarbohydratesCarbohydratesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesPlant PreparationsBiological ProductsComplex MixturesBeveragesAlcoholsOrganic Chemicals

Results Point of Contact

Title
Michael Bremmer, PhD
Organization
University of North Carolina at Chapel Hill

Study Officials

  • Jimikaye Courtney, PhD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
participant will be blinded to the session order in which they receive either the dietary supplements (fiber and green tea) or a placebo.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: within-subjects placebo-controlled design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2024

First Posted

August 29, 2024

Study Start

September 3, 2024

Primary Completion

April 9, 2025

Study Completion

April 9, 2025

Last Updated

December 5, 2025

Results First Posted

December 5, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
beginning 9 and continuing for 36 months following publication
Access Criteria
Investigator has approved IRB, IEC, or REB and an executed data use/sharing agreement with UNC.

Locations